Boss of Open Orphan volunteers for Covid-19 drug trial

Executive chairman of the Irish drug testing firm, Cathal Friel, wants to be part of study which involves being infected by the virus

25th October, 2020
Boss of Open Orphan volunteers for Covid-19 drug trial
Cathal Friel, Open Orphan’s executive chairman, said he had volunteered to be among those involved in the study, although he would not be part of the first group

The head of Open Orphan, the Irish drug trials and testing company, has said he has volunteered to be infected with a dose of Covid-19 as part of a human study into the virus.

Open Orphan’s subsidiary hVIVO won a £40 million (€44 million) contract with the British government last week which will see it conduct what is termed a human challenge trial, that will involve volunteers being given a strain of Covid-19 to study...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Tánaiste launches Redesdale’s €75 million food fund

This Working Life: How to avoid the risks of remote working